SEC Form 3 · accession 0000200406-26-000177
JOHNSON & JOHNSON · JNJ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Cavanaugh
Officer — EVP WW Chair, Innovative Med.
Period of report
Sep 1, 2026
Accepted (ET)
Sep 1, 2026 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000200406
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 71 | D | ||
| Common StockF1 | holding | — | — | — | 428 | I | By 401k |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy)F2 | $243.45 | holding | — | — | — | — | Feb 15, 2036 | Common Stock | 15,839 | — | D |
| Employee Stock Options (Right to Buy)F2 | $156.15 | holding | — | — | — | — | Feb 15, 2035 | Common Stock | 25,493 | — | D |
| Employee Stock Options (Right to Buy)F2 | $157.92 | holding | — | — | — | — | Feb 15, 2034 | Common Stock | 23,311 | — | D |
| Employee Stock Options (Right to Buy)F2 | $162.75 | holding | — | — | — | — | Feb 13, 2033 | Common Stock | 15,081 | — | D |
| Employee Stock Options (Right to Buy)F3 | $165.89 | holding | — | — | — | Feb 14, 2025 | Feb 14, 2032 | Common Stock | 11,906 | — | D |
| Employee Stock Options (Right to Buy)F3 | $164.62 | holding | — | — | — | Feb 8, 2024 | Feb 8, 2031 | Common Stock | 14,383 | — | D |
| Employee Stock Options (Right to Buy)F3 | $151.41 | holding | — | — | — | Feb 10, 2023 | Feb 10, 2030 | Common Stock | 16,543 | — | D |
| Restricted Share UnitsF4 | — | holding | — | — | — | — | — | Common Stock | 2,275 | — | D |
| Restricted Share UnitsF5 | — | holding | — | — | — | — | — | Common Stock | 2,097 | — | D |
| Restricted Share UnitsF6 | — | holding | — | — | — | — | — | Common Stock | 965 | — | D |
Explanation of responses
- F1Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2026).
- F2Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
- F3Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
- F4Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
- F5Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
- F6Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.